- Home
- FTFT vs EVOK Comparison
FTFT vs EVOK Comparison
Compare FTFT & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- EVOK
- Stock Information
- Founded
- FTFT N/A
- EVOK 2007
- Country
- FTFT United States
- EVOK United States
- Employees
- FTFT N/A
- EVOK N/A
- Industry
- FTFT Business Services
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- EVOK Health Care
- Exchange
- FTFT Nasdaq
- EVOK Nasdaq
- Market Cap
- FTFT 8.7M
- EVOK 7.0M
- IPO Year
- FTFT N/A
- EVOK 2013
- Fundamental
- Price
- FTFT $0.30
- EVOK $5.07
- Analyst Decision
- FTFT
- EVOK
- Analyst Count
- FTFT 0
- EVOK 0
- Target Price
- FTFT N/A
- EVOK N/A
- AVG Volume (30 Days)
- FTFT 456.9K
- EVOK 40.0K
- Earning Date
- FTFT 11-19-2024
- EVOK 11-07-2024
- Dividend Yield
- FTFT N/A
- EVOK N/A
- EPS Growth
- FTFT N/A
- EVOK N/A
- EPS
- FTFT N/A
- EVOK N/A
- Revenue
- FTFT $18,543,659.00
- EVOK $8,617,036.00
- Revenue This Year
- FTFT N/A
- EVOK $97.35
- Revenue Next Year
- FTFT N/A
- EVOK $99.52
- P/E Ratio
- FTFT N/A
- EVOK N/A
- Revenue Growth
- FTFT N/A
- EVOK 100.35
- 52 Week Low
- FTFT $0.26
- EVOK $3.54
- 52 Week High
- FTFT $2.60
- EVOK $14.04
- Technical
- Relative Strength Index (RSI)
- FTFT 42.24
- EVOK 56.74
- Support Level
- FTFT $0.26
- EVOK $4.33
- Resistance Level
- FTFT $0.36
- EVOK $5.75
- Average True Range (ATR)
- FTFT 0.05
- EVOK 0.41
- MACD
- FTFT -0.01
- EVOK 0.14
- Stochastic Oscillator
- FTFT 24.35
- EVOK 60.69
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.